Brookstone Capital Management

Position in NBIX — Neurocrine Biosciences Inc

CIK 1599584 WHEATON, IL

Position in NBIX

as of Mar 31, 2026 · filed Apr 16, 2026 Compact

Position Value

$665,287

+$83,643 QoQ

Shares Held

5,050

+23.1% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Brookstone Capital Management holds $4,588,273 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	4,471	$2,651,213
2	HROW	Harrow, Inc.	28,884	$1,018,449
3	NBIX	Neurocrine Biosciences Inc This page	5,050	$665,287
4	ZTS	Zoetis Inc.	2,143	$253,324

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$665,287	5,050	+23.1%	Shares	Sole	2026-04-16
2025-12-31	$581,644	4,101	-5.8%	Shares	Sole	2026-01-15
2025-09-30	$611,074	4,353	—	Shares	Sole	2025-10-15
No filing history on record for this holder in this stock.